These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36685904)

  • 1. A circadian rhythm-related gene signature for prognosis, invasion and immune microenvironment of breast cancer.
    Wang MH; Liu X; Wang Q; Zhang HW
    Front Genet; 2022; 13():1104338. PubMed ID: 36685904
    [No Abstract]   [Full Text] [Related]  

  • 2. A Circadian Rhythm-related Signature to Predict Prognosis, Immunei Infiltration, and Drug Response in Breast Cancer.
    Chu M; Huang J; Wang Q; Fang Y; Cui D; Jin Y
    Curr Med Chem; 2024 Sep; ():. PubMed ID: 39279697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity.
    Chi H; Yang J; Peng G; Zhang J; Song G; Xie X; Xia Z; Liu J; Tian G
    Front Immunol; 2023; 14():1091218. PubMed ID: 36969232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of circadian rhythm-related genes and establishment of a prognostic scoring system for lung adenocarcinoma with experimental verification: a bioinformatics analysis.
    Zhang F; Zhang Q; Jiang T; Fan X; Wang W; Liu L; Liu K
    J Thorac Dis; 2022 Oct; 14(10):3934-3954. PubMed ID: 36389336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis.
    Wu Z; Wan J; Wang J; Meng X; Qian H
    Biochem Biophys Rep; 2022 Mar; 29():101203. PubMed ID: 35059509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a breast cancer prognosis model based on alternative splicing and immune infiltration.
    Zhang D; Lu W; Zhuo Z; Mei H; Wu X; Cui Y
    Discov Oncol; 2022 Aug; 13(1):78. PubMed ID: 35988113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.
    Zhang B; Wang Q; Fu C; Jiang C; Ma S
    Ann Transl Med; 2019 Dec; 7(23):730. PubMed ID: 32042746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of cuproptosis-related long non-coding RNA signature and personalized therapeutic strategy of breast cancer patients.
    Guo Q; Qiu P; Pan K; Lin J
    Front Oncol; 2022; 12():1081089. PubMed ID: 36620596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
    Cao J; Liang Y; Gu JJ; Huang Y; Wang B
    Front Genet; 2022; 13():991162. PubMed ID: 36353118
    [No Abstract]   [Full Text] [Related]  

  • 12. A circadian rhythm-related gene signature associated with tumor immunity, cisplatin efficacy, and prognosis in bladder cancer.
    Zhou R; Chen X; Liang J; Chen Q; Tian H; Yang C; Liu C
    Aging (Albany NY); 2021 Dec; 13(23):25153-25179. PubMed ID: 34862329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
    Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
    Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pyroptosis-Related Risk Genes APOBEC3D, TNFRSF14, and RAC2 Were Used to Evaluate Prognosis and as Tumor Suppressor Genes in Breast Cancer.
    Chen Q; Jun H; Yang C; Yang F; Xu Y
    J Oncol; 2022; 2022():3625790. PubMed ID: 36059808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTPRO-related CD8
    Dong H; Xie C; Yao Z; Zhao R; Lin Y; Luo Y; Chen S; Qin Y; Chen Y; Zhang H
    Front Immunol; 2022; 13():947841. PubMed ID: 36003382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRS: a circadian rhythm score model for predicting prognosis and treatment response in cancer patients.
    Liu Y; Guo S; Sun Y; Zhang C; Gan J; Ning S; Wang J
    J Transl Med; 2023 Mar; 21(1):185. PubMed ID: 36895015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
    Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
    Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.